Orthogon Therapeutics Celebrates Major Technical Milestone and Secures Additional $6M Toward a Pioneering Drug for BK Virus Published: Jul 24, 2023 In an exciting development, Orthogon Therapeutics LLC, a leading player in the field of antiviral therapeutics, has achieved a significant breakthrough. The company's flagship molecule has successfully completed acute toxicity studies, marking a majo..
Wavely Diagnostics, a digital diagnostics company, has recently secured $1.35 million in funding to further advance its digital diagnostics platform for virtual pediatric care. With this latest round of funding, Wavely's total funding raised now stands at an impressive $6.35 million. The additional funds will be instrumental in expediting the commercial launch of their smartphone-based app desig..
Bausch Health Companies Inc. (NYSE/TSX:BHC) and KKR have recently announced a significant financing facility agreement worth $600 million. The agreement involves Bausch Receivables Funding LP, a subsidiary of Bausch Health, entering into a non-recourse financing facility with KKR and its credit funds and accounts. This facility will be backed by specific accounts receivables originated by anothe..
Abeona Therapeutics Inc. (Nasdaq: ABEO) has successfully raised $25 million through a registered direct offering under Nasdaq rules. The funds were primarily raised to support the launch preparations for the Company's EB-101 Biologics License Application (BLA) submission and potential approval. Abeona entered into definitive agreements with existing institutional investors, issuing and selling 3..
Susan G. Komen® Announces 2023 Grants to Accelerate Research Discoveries and Improve Outcomes for Breast Cancer Patients Published: Jun 28, 2023   $19.3 Million in Funding to Leading and Emerging Scientists; Grants will Advance Precision Medicine and Eliminate Disparities in Breast Cancer DALLAS, June 28, 2023 /PRNewswire/ -- Susan G. Komen for the Cure®, the world's leading breast cancer or..
Vyriad, Inc. has announced an expansion of a Phase 1 trial at Mayo Clinic for patients with peripheral T-cell lymphoma (PTCL) using Voyager-V1 therapy after encouraging initial results. Regeneron Pharmaceuticals is co-developing the investigational therapy to treat patients with recurrent or treatment resistant cancers by dissolving cancer cells and stimulating the patient's immune system to pre..
The global stem cell therapy market is projected to reach USD 31.41 billion by 2030, growing at a CAGR of 13.73% during the forecast period from 2023 to 2030. The market size was estimated at USD 11.22 billion in 2022 and is expected to expand to USD 24.29 billion by 2028. Factors driving the growth of the market include accelerated funding for stem cell therapies, rising interest in stem cell-b..
The global stem cell therapy market is projected to reach a size of USD 31.41 billion by 2030, growing at a CAGR of 13.73% during the forecast period from 2023 to 2030. The market was valued at USD 11.22 billion in 2022 and is expected to expand to USD 24.29 billion by 2028 due to factors such as accelerated funding for stem cell therapies, rising interest from investors, increased awareness of ..
